-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II

Symposia: Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Patrice Chevallier, MD1, Thibault Leguay2*, Rathana KIM, PharmD3*, Marc Delord4*, Michael Doubek, MD, PhD5, Francoise Huguet, MD6*, Aurelie Cabannes-Hamy, MD7*, Ulla Wartiovaara-Kautto, MD, PhD8, Colombe Saillard, MD9*, Emmanuel Raffoux10*, Thomas Cluzeau, MD, PhD11, Stephane Lepretre, MD12*, Marie Balsat13*, Anna Berceanu, MD14*, Nicolas Boissel, MD, PhD15, Claude Gardin, MD16*, Emmanuelle Clappier17*, Herve Dombret, MD PhD18 and Philippe Rousselot, MD, PhD19*

1Hematology Department, Nantes University Hospital, Nantes, France
2Bordeaux University Hospital, Pessac, FRA
3Hematology laboratory, Assistance Publique Des Hopitaux De Paris (AP-HP) - Universite Paris Descartes -, Paris, Ile-de-France, France
4Direction à la recherche clinique et à l'innovation, Centre hospitalier de Versailles, Le Chesnay, France
5Department of Internal Medicine - Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
6Service d'Hematologie, CHU de Toulouse- Institut Universitaire de Cancérologie de Toulouse Oncopole, Toulouse, France
7Hematology Unit, Versailles Hospital, Le Chesnay, France
8Department of Hematology, University of Helsinki, Helsinki, Finland
9Institut Paoli Calmettes, Marseille, France
10Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
11Département d'Hématologie Clinique, Université Côte d'Azur, CHU Nice, Nice, Provence Alpes Cote d'Azur, France
12Centre Henri Becquerel, Rouen, Rouen, FRA
13Clinical hematology service, Hospices Civils de Lyon, Lyon, France
14Clinical Hematology, Besançon University Hospital, Besançon, France
15Hematology Adolescent and Young Adult Unit, France, Paris Cedex 10, France
16Hematology Department, Avicenne Hospital, Bobigny, France
17Hematology Laboratory and INSERM U944, Université de Paris, Saint-Louis Hospital, Paris, France
18Hopital Saint-Louis, Assistance Publique - Hopitaux De Paris (AP-HP), Paris, FRA
19Hematology Department, Centre Hospitalier de Versailles, LE CHESNAY CEDEX, France

Sarah K Tasian, MD1,2, Deborah S Hunter, PhD3*, I-Ming L Chen4, Richard C Harvey, PhD4, Andrew J. Carroll, PhD5, Elizabeth Wagner6*, Shalini C Reshmi, PhD6, Michael J Borowitz, MD PhD7, Brent L. Wood, MD PhD8, Jeannie Daniel, PhD3*, Meenakshi Devidas, PhD, MBA9, Elizabeth A. Raetz, MD10, Stephen P. Hunger, MD11, Albert Assad, MD3* and Mignon L. Loh, MD12

1Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
2Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
3Incyte Corporation, Wilmington, DE
4University of New Mexico Cancer Center, Albuquerque, NM
5Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
6Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH
7Departments of Pathology and Oncology, Johns Hopkins Hospital, Baltimore, MD
8Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
9Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
10Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
11Department of Pediatrics and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
12Division of Hematology, Oncology, BMT, and Cellular Therapies, Seattle Children's Hospital, Seattle, WA

Giovanni Marconi, MD1, Alfonso Piciocchi, MS2*, Sabina Chiaretti, MD, PhD3, Cristina Papayannidis, MD, PhD4, Monia Lunghi, MD5*, Prassede Salutari, MD6*, Patrizia Zappasodi7*, Alessandro Rambaldi, MD8, Attilio Olivieri, MD9, Maurizio Cavallari, MD10*, Stefano Soddu2*, Nicola S Fracchiolla, MD11*, Federica Gigli, MD12*, Chiara Cattaneo, MD13*, Daniele Giovanni Mattei, MD14, Anna Candoni, MD15*, Giovanni Grillo, MD16*, Maria Chiara Abbenante, MD17*, Ernesta Audisio18*, Massimiliano Bonifacio, MD19*, Albana Lico, MD20*, Roberto Massimo Lemoli, MD21,22*, Paolo De Fabritiis, MD23*, Felicetto Ferrara, MD24*, Martina Rachele Marino25*, Monica Messina26*, Anna Ferrari, PhD27*, Valentina Robustelli, PhD28,29*, Jacopo Nanni, MD30*, Irene Della Starza, PhD31*, Giorgia Simonetti32*, Maria Stefania De Propris, PhD31*, Maria Teresa Bochicchio32*, Marco Vignetti33*, Paola Fazi, MD2* and Giovanni Martinelli, MD34

1IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori”(IRST),, Meldola, Italy
2GIMEMA Foundation, Rome, Italy
3Umberto I - Rome, AOU Policlinico, Rome, Italy
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
5Division of Hematology Department of Translational Medicine , AOU Maggiore della Carità, Università del Piemonte Orientale, Novara, ITA
6Dipartimento Oncologia Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy
7Department of Hematology Oncology, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
9Hematology, Università Politecnica Delle Marche-AOU Ospedali Riuniti, Ancona, Ancona, ITA
10Mestre, Ospedale serenissima, Mestre, Italy
11Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, MILANO, Italy
12European Institute of Oncology, Milan, Italy
13Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
14Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
15Division of Hematology and Bone Marrow Transplantation, Clinica Di Ematologia E Unità Di Terapie Cellulari 'carlo Melzi'-Azienda, Udine, Italy
16Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy, Italy
17university of Bologna, Istituto di Oncoematologia L. e A. Seragnoli, Bologna, Italy
18TORINO CITTÀ DELLA SALUTE E DELLA SCIENZA, Torino, Italy
19Department of Medicine, Section of Hematology, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy
20Hematology and Clinical Immunology, Department of Medicine, AULSS 8 BERICA - OSPEDALE DI VICENZA, Vicenza, Italy
21IRCCS San Martino Hospital, Genoa, Italy
22University of Genoa, Clinic of Hematology, Department of Internal Medicine (DiMI), Genoa, Italy
23Department of Hematology S. Eugenio Hospital, Rome, Italy, Roma, Italy
24+390817472241, Napoli, Italy
25GIMEMA Foundation, ROMA, Italy
26Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
27Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy
28Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
29Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
30Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
31Hematology, Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy
32Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
33GIMEMA Foundation, Roma, ITA
34IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy

Pilar Martínez Sánchez, M.D.1*, Gerhard Zugmaier, M.D., PhD2, Paul Gordon, M.D.3*, Elias Jabbour, MD4, José J. Rifón Roca, M.D.5*, Stefan Schwartz, M.D.6*, Erika Borlenghi, M.D.7*, Francoise Huguet, MD8*, Jesús María Hernández-Rivas, MD, PhD9, Federico Lussana, MD, PhD10*, Céline Berthon, M.D.11*, Priti Kadu, MSc12*, Hansen Wong, PhD13*, Ana Markovic, PhD3*, Yuliya Katlinskaya, PhD13* and Alessandro Rambaldi, MD14,15

1Hematology Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, Madrid, Spain
2Amgen Research GmbH, Munich, Germany
3Amgen Inc., Thousand Oaks, CA
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain
6Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
7Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
8Department of Hematology, Institut Universitaire du Cancer-Oncopole CHU de Toulouse, Toulouse, France
9Cancer Research Center of Salamanca (USAL-CSIC), Salamanca, Spain
10Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Please Choose A State, Italy
11Cancer Heterogeneity, Plasticity and Resistance to Therapies, Univ. Lille, Lille, France
12IQVIA RDS (India) Private Limited, Bangalore, India
13Amgen Inc., South San Francisco, CA
14Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
15Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Piazza OMS, Bergamo, Italy

Bela Patel Wrench, MD1*, Amy A. Kirkwood, MSc2*, Krisztina Zuborne Alapi, MSc3*, Laura Clifton-Hadley, BSc, PhD2*, SooWah Lee, MSc3*, David I. Marks, MD, PhD4*, Anthony V. Moorman5, Nicholas J. Morley, MBBS PhD6*, Pip Patrick, PhD, MSc, MA2*, Zaynab Rana, MSc7*, Clare J. Rowntree, MBBS PhD8*, John A. Snowden, MBBS PhD6* and Adele K. Fielding, MBBS, PhD3

1CRUK Barts Centre, Queen Mary University of London, London, United Kingdom
2Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
3UCL Cancer Institute, London, United Kingdom
4Bristol University Hospitals, Bristol, United Kingdom
5Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom
6Sheffield University Teaching Hospitals, Sheffield, United Kingdom
7Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom
8Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom

Daniel Nguyen, MD, PhD1, Elias Jabbour, MD2, Nicholas Short, MD3, Ghayas C. Issa, MD4, Musa Yilmaz, MD5, Naval Daver, MD2, Naveen Pemmaraju, MD2, Kelly S. Chien, MD2, Lucia Masarova, MD2, Farhad Ravandi, MD2, Nitin Jain, MD5, Wuliamatu Deen, BSN, RN2*, Min Zhao2*, Christopher Loiselle, BS2*, Lourdes Waller2*, Glenda Banks2*, Rebecca Garris2* and Hagop Kantarjian, MD6

1Department of Medicine, The University of Texas Health Science Center at Houston, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Juliëtte Schmidt1*, Peter M. Hoogerbrugge, MD, PhD1,2, Caroline Lindemans, MD, PhD1,3*, Stefan Nierkens, PhD1,4,5*, Robert S. Van Binnendijk, PhD6*, Louis J Bont, MD, PhD7* and Wim J.E. Tissing, MD, PhD1,8*

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Dutch Childhood Oncology Group, Utrecht, Netherlands
3Utrecht University, Utrecht, Netherlands
4Center for Translational Immunology, University Medical Center, Utrecht, Netherlands
5Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands
6Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, Netherlands
7Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, Utrecht, Netherlands
8Pediatric Oncology/Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Yajaira Valentine Jimenez-Antolinez, MD1*, Samantha Fierro Sáenz, MD2, Lilia Edith Carrizales Torres, MD1*, Julia Esther Colunga Pedraza, MD1*, Hernan Ramirez-Duran1*, Andres Gomez-De Leon, MD2, David Gómez-Almaguer, MD2 and Oscar Gonzalez, MD1*

1Pediatric Hematology, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González, Monterrey, Mexico
2Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González, Monterrey, Mexico

Elias Jabbour, MD1, Ibrahim Aldoss, MD2, Shaun Fleming, FRACP FRCPA3*, Ashish Bajel, MBBS, DM4, Paul Cannell, MBBS, FRACP, FRCPA5, Monika Brüggemann, MD6*, Gerhard Zugmaier, M.D., PhD7, Joan Morris, MD8*, Yuqi Chen, PhD8*, Sonny Powar, MBChB, MSc9*, Hansen Wong, PhD10*, Björn Steffen, MD11*, Hagop Kantarjian, MD1 and Nicola Goekbuget, MD12

1MD Anderson Cancer Center, Houston, TX
2City of Hope, Duarte, CA
3The Alfred, Melbourne, VIC, Australia
4Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
5Fiona Stanley Hospital, Murdoch, Western Australia, Australia
6University Medical Center Schleswig-Holstein, Kiel, Germany
7Amgen Research GmbH, Munich, Germany
8Amgen Inc., Thousand Oaks, CA
9Amgen Inc., Uxbridge, United Kingdom
10Amgen Inc., South San Francisco, CA
11Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
12Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany

Xiaoyan Zhang1*, Xiaofan Zhu, MD2, Ju Gao, PhD3*, Jie Yu4*, Shaoyan Hu, MD, PhD5, Hua Jiang, MD6*, Xin Tian, PhD7*, Ningling Wang, PhD8*, Aiguo Liu9*, Runming Jin, MD10* and Lirong SUN, PhD11*

1Division of Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China
2Department of Pediatric Blood Diseases Center, Institute of Hematology & Blood Diseases Hospital, Tianjin, China
3West China Second University Hospital, Sichuan University; Key Laboratory of Chronobiology (Sichuan University), National Health Commission of China, Chengdu, China
4Chongqing Medical University, Chongqing, China
5Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
6hematology and oncology, Guangzhou Women and Children's Medical Center, Guangzhou, CHN
7Kunming Children's Hospital, Kunming, China
8Anhui medical university second affiliated hospital, Hefei, Anhui, CHN
9Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China
10Union Hospital Affiliated To Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
11Department of Pediatrics, Affiliated Hospital of Qingdao University, Qingdao, CHN

Jessica C Hochberg, MD1*, Javier Oesterheld, MD2*, Aliza Gardenswartz, MD3*, Liana Klejmont, Pharm D4*, Jaclyn Basso, RN, MSN, PNP4*, Elizabeth Mintzer5*, Lauren Harrison, RN, MSN3*, Michael J Borowitz, MD PhD6, Michael R. Loken, PhD7* and Mitchell S Cairo8

1Department of Pediatrics, New York Medical College, Hawthorne, NY
2Levine Children's Hosp., Charlotte, NC
3Department of Pediatrics, New York Medical College, Valhalla, NY
4Pediatrics, New York Medical College, Valhalla, NY
5New York Medical College, Valhalla, NY
6Departments of Pathology and Oncology, Johns Hopkins Hospital, Baltimore, MD
7Hematologics, Inc., Seattle, WA
8New York Medical College, Departments of Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY

*signifies non-member of ASH